FTSE in positive territory
Pharmaceuticals firm Shire injected enthusiasm into London shares today as investors welcomed news it had settled a patent dispute.
Shire’s market value lifted 7% after it revealed US group Impax would be allowed to make generic versions of Adderall XR by 2010 and would pay Shire a royalty from the sales.